Taipei Exchange - Delayed Quote TWD

Pacific Hospital Supply Co., Ltd (4126.TWO)

92.50
0.00
(0.00%)
At close: 1:30:37 PM GMT+8
Loading Chart for 4126.TWO
  • Previous Close 92.50
  • Open 92.70
  • Bid 92.30 x --
  • Ask 92.80 x --
  • Day's Range 92.30 - 93.50
  • 52 Week Range 80.80 - 100.00
  • Volume 29,616
  • Avg. Volume 76,456
  • Market Cap (intraday) 6.716B
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 14.30
  • EPS (TTM) 6.47
  • Earnings Date Aug 4, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 4.80 (5.19%)
  • Ex-Dividend Date Jul 3, 2024
  • 1y Target Est 95.00

Pacific Hospital Supply Co., Ltd., together with its subsidiaries, manufactures, processes, and sells medical disposable products and equipment in Taiwan. The company's disposable medical devices include tubings, bags, bottles, closed wound drainage systems, surgical suction instruments, respiratory therapy products, and other products. It also provides medical gas systems, such as medical gas outlets, secondary equipment, accessories, and pipeline equipment, as well as pipeline system design and maintenance services. Pacific Hospital Supply Co., Ltd. offers its products for health c are industry clients. The company also exports its products to approximately 80 countries and regions. Pacific Hospital Supply Co., Ltd. was founded in 1977 and is headquartered in Miaoli, Taiwan.

www.pahsco.com.tw

807

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4126.TWO

View More

Performance Overview: 4126.TWO

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4126.TWO
5.23%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.34%

1-Year Return

4126.TWO
6.47%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.67%

3-Year Return

4126.TWO
55.15%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
35.05%

5-Year Return

4126.TWO
70.12%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
98.07%

Compare To: 4126.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4126.TWO

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    6.72B

  • Enterprise Value

    5.97B

  • Trailing P/E

    14.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.83

  • Price/Book (mrq)

    2.18

  • Enterprise Value/Revenue

    2.50

  • Enterprise Value/EBITDA

    8.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.82%

  • Return on Assets (ttm)

    8.12%

  • Return on Equity (ttm)

    15.72%

  • Revenue (ttm)

    2.39B

  • Net Income Avi to Common (ttm)

    472.91M

  • Diluted EPS (ttm)

    6.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    13.84%

  • Levered Free Cash Flow (ttm)

    329.11M

Research Analysis: 4126.TWO

View More

Company Insights: 4126.TWO

Research Reports: 4126.TWO

View More

People Also Watch